KALA BIO Inc.

KALA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.55

+$0.01 (+2.04%)

At close: Sep 21, 2026, 3:59 PM ET

$0.57

+$0.02 (+3.64%)

After-hours: Sep 21, 2026, 7:40 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.04%

(1D)

Rating

Updated: Aug 24, 2026

28.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $10.64M

1D Range

0.54 0.58

52W Range

0.49 988.50

Valuation (TTM)

PE -0.02

PB 1.18

EV/EBITDA -0.38

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $18.25

Cash Flow

FCF Yield -186.7%

SBC Adj. FCF Yield -203.9%

SBC Impact -9.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | -97.6%

Dil EPS 3Y | 5Y -29.7% | 51.3%

FCF 3Y | 5Y 21.8% | 41.6%

Returns

ROA -95.3%

ROE -222.3%

ROIC -232.1%

Financial Health

Net Cash

$7.23M

Current Ratio 6.88

Interest Coverage -19.01

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanopart...

Sector Healthcare

Industry Biotechnology

Employees 6

IPO Date Jul 19, 2017

Website www.kalarx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$18.25

Upside

+3218.18%

Buy (0)

Hold (4)

Sell (0)

Analyst Details ➞